Texas 2013 - 83rd Regular

Texas House Bill HB3262

Filed
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to pharmacy benefit managers contracting with the child health plan program, the Medicaid managed care program, and health plans for certain government employees.

Impact

The impact of HB 3262 extends to several areas of healthcare regulation and delivery within the state. By establishing clear guidelines for how PBMs calculate and update the maximum allowable costs for medications, the legislation is expected to enhance fairness and predictability in healthcare reimbursement. Moreover, this bill could lead to improved access to medications for children enrolled in state health programs, as well as greater accountability for PBMs operating within Texas. It also aims to alleviate some of the administrative burden that pharmacies may face when dealing with reimbursement issues.

Summary

House Bill 3262 focuses on improving transparency in the contracting process between pharmacy benefit managers (PBMs) and state health programs, specifically the Medicaid managed care program and the child health plan program. The bill outlines specific requirements that must be included in contracts between PBMs and these programs, aiming to ensure that pricing and reimbursement structures are clear and accessible to all stakeholders involved. By mandating uniformity in maximum allowable cost calculations for medications, the bill intends to protect pharmacies and patients from unexpected cost fluctuations that may arise from unclear pricing mechanisms.

Contention

Notable points of contention surrounding this bill may arise from the diverse interests of stakeholders in the healthcare industry. Supporters of increased transparency, such as pharmacy groups and healthcare advocates, argue that these measures are necessary to protect consumers and ensure equitable access to medications. Conversely, some PBMs and insurance groups may view the regulations as overly restrictive, potentially hindering their flexibility in contract negotiations and pricing strategies. The balance between regulation and operational flexibility will likely be a central theme in discussions as the bill progresses.

Companion Bills

TX SB1431

Identical Relating to pharmacy benefit managers contracting with the child health plan program, the Medicaid managed care program, and health plans for certain government employees.

Similar Bills

TX HB1137

Relating to the use of maximum allowable cost lists under a Medicaid managed care pharmacy benefit plan.

TX HB3388

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX SB1106

Relating to the use of maximum allowable cost lists under a Medicaid managed care pharmacy benefit plan.

TX HB3366

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX SB1283

Relating to the availability under Medicaid of certain drugs used to treat human immunodeficiency virus or prevent acquired immune deficiency syndrome.

TX SB1096

Relating to the Medicaid managed care program, including the provision of pharmacy benefits.

TX HB1133

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX HB4055

Relating to the availability under Medicaid of certain drugs used to treat human immunodeficiency virus or prevent acquired immune deficiency syndrome.